Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jitongning Tablet in Active Axial Spondyloarthritis
NCT03932019Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of jitongning in axial spondyloarthritis (axSpA), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jun 2019; status: completed.
02
Drugs
jitongning
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT03932019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03932019.